[Study of ganglioside therapy in maxillofacial surgery].
56 patients have been treated with cerebral gangliosides by the Authors. They underwent a maxillo-facial operation due to various pathological reasons (traumas, tumors, malformations). They presented secondary symptoms such as neurological deficits of the V and VII paired cranial nerves. The recovery from neurological sensitive, motor deficit have been positive, and the Authors have been encouraged to the therapeutical use of gangliosides in the mentioned pathology and to a wider experiment of the test product.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005154:Facial Nerve; D005158:Facial Paralysis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005732:Gangliosides / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008337:Mandibular Fractures / Q000601:surgery; D008446:Maxillofacial Injuries / Q000601:surgery*; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000601:surgery*; D010255:Paranasal Sinus Neoplasms / Q000601:surgery; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications; D011378:Prognathism / Q000601:surgery*; D012466:Salivary Gland Diseases / Q000601:surgery*; D012468:Salivary Gland Neoplasms / Q000601:surgery*; D014276:Trigeminal Nerve
D005732:Gangliosides
Contributo della terapia con gangliosidi in chirurgia maxillo facciale.